Archives of gynecology

, Volume 231, Issue 4, pp 253–261 | Cite as

Chemotherapy for advanced recurrent carcinoma of the cervix

A report on the treatment of 22 patients
  • K. von Maillot
  • I. M. Ranger
Original Papers


In 22 patients with advanced squamous-cell carcinoma of the cervix, chemotherapy with adriamycin and methotrexate was attempted. Remission occurred in five patients, being complete in two of these. The median duration of remission was 8 months. In eight patients, the course of the disease was stabilized for at least 3 months. The median survival time was 3 months for the group of “failures”, 11.5 months for those with stable disease, and 21 months for patients in remission: The most favourable course of the disease was observed in the two patients with complete remission; they survived for 31 and 32 months, respectively, after the start of chemotherapy.

Key words

Advanced carcinoma of the cervix Recurrent carcinoma of the cervix Chemotherapy Adriamycin Methotrexate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alberts DS, Ignoffo R (1978) Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix. Cancer Treat Rep 62: 143–144PubMedGoogle Scholar
  2. 2.
    Barlow JJ, Piver MS, Chuang JT, Cortes EP, Ohnuma T, Holland JF (1973) Adriamycin and bleomycin alone and in combination in gynecologic cancers. Cancer 32: 735–743PubMedGoogle Scholar
  3. 3.
    Bond WH, Arthur K, Banks AJ, Freeman WE, Holme GM, Newsholme GA, Ward HWC, Jones WE, Chowdhury MS, Brown I (1976) Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the cervix. Clin Oncol 2: 173–178PubMedGoogle Scholar
  4. 4.
    Cohen CJ, Gastro-Marin A, Deppe G, Bruckner HW, Holland JF (1978) Chemotherapy of advanced recurrent cervical cancer with Platinum II. Proc Am Assoc Cancer Res 19: 401, Abstr C 379Google Scholar
  5. 5.
    Conroy JF, Lewis GC, Brady LW, Brodsky I, Kalm SB, Ross D, Nuss R (1976) Low dose bleomycin and methotrexate in cervical cancer. Cancer 37: 660–664PubMedGoogle Scholar
  6. 6.
    De Palo GM, Bajetta E, Beretta G, Bonadonna G (1976) Adriamycin plus bleomycin versus cyclophosphamide plus vincristine in advanced carcinoma of the uterine cervix. Tumori 62: 113–122PubMedGoogle Scholar
  7. 7.
    Forney JP, Morrow PC, Di Saja PJ, Futoran RJ (1975) Seven drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract. Am J Obstet Gynecol 123: 748–752PubMedGoogle Scholar
  8. 8.
    Friedman M, Turbow MM, Carter SK (1980) Sequential combination of bleomycin and mitomycin C in recurrent and metastatic squamous cell carcinoma of the cervix. ASCO Abstr C-434, Proc Am Assoc Cancer Res Abstr 434: 428Google Scholar
  9. 9.
    Guthrie D, Way S (1974) Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined. Obstet Gynecol 44: 586–589PubMedGoogle Scholar
  10. 10.
    Guthrie D, Way S (1978) The use of adriamycin and methotrexate in carcinoma of the cervix. Obstet Gynecol 52: 349–354PubMedGoogle Scholar
  11. 11.
    Latzko W (1914) Behandlung hochsitzender Blasen- und Mastdarmscheidenfisteln nach Uterusexstirpation mit hohem Scheidenverschluß. Zentralbl Gynäkol 38: 906–907Google Scholar
  12. 12.
    Miyamoto T, Kakabe Y, Watanabe M, Terasima T (1978) Effectiveness of a sequential combination of bleomycin and mitomycin C on an advanced cervical cancer. Cancer 41: 403–414PubMedGoogle Scholar
  13. 13.
    Monfardini S, de Palo GM, Bajetta E, Veronesi U (1974) Adriamycin plus bleomycin versus CTX plus VCR in advanced carcinoma of the cervix. Proc Am Assoc Cancer Res: 15: 91, Abstr 362Google Scholar
  14. 14.
    Morrow CP (1980) Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treatment by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 10: 105–110CrossRefPubMedGoogle Scholar
  15. 15.
    Natale N, Mangioni C, Bolis G (1975) Combination of adriamycin and bleomycin in the treatment of advanced cervical cancer. Proceedings of the 9th International Congress of Chemotherapy, London, pp 501–505Google Scholar
  16. 16.
    Ober KG, Huhn FO (1962) Die Ausbreitung des Zervixkrebses auf die Parametrien und die Lymphknoten der Beckenwand. Arch Gynecol 197: 262Google Scholar
  17. 17.
    Rossof AH, Talley RW, Stephens R, Thigpen T, Samson MK, Groppe C Jr, Eyre HJ, Fisher R (1979) Phase II evaluation of cis-Dichlorodiamineplatinum (II) in advanced malignancies of the genitourinary and gynecologic organs: A Southwest Oncology Group Study. Cancer Treat Rep 63: 1557–1564PubMedGoogle Scholar
  18. 18.
    Thigpen T, Vance RB, Balducci L, Blessing J (1981) Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma. Cancer 48: 658–665PubMedGoogle Scholar
  19. 19.
    Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J (1981) Cis-Platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecology Oncology Group. Cancer 48: 899–903PubMedGoogle Scholar
  20. 20.
    Vogl SE, Moukhtar M, Calanog A, Greenwald EH, Kaplan BH (1980) Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C and cis-diaminedichloroplatinum. Cancer Treat Rep 64: 1005–1007PubMedGoogle Scholar
  21. 21.
    Zander J, Balzer J, Lohe KJ, Ober KG, Kaufmann C (1981) Carcinoma of the cervix: An attempt to individualize treatment. Am J Obstet Gynecol 139: 752–759PubMedGoogle Scholar

Copyright information

© J. F. Bergmann Verlag 1982

Authors and Affiliations

  • K. von Maillot
    • 1
  • I. M. Ranger
    • 1
  1. 1.Frauenklinik der Universität Erlangen-Nürnberg (Director: Prof. Dr. K. G. Ober)ErlangenFederal Republic of Germany

Personalised recommendations